Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.19 +0.15 (+0.60%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

3 Stocks Under $50 Walking a Fine Line

August 25, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

Topics Artificial Intelligence

2 Reasons to Watch ZTS and 1 to Stay Cautious

August 25, 2025

Over the past six months, Zoetis’s shares (currently trading at $156.80) have posted a disappointing 7% loss, well below the S&P 500’s 8.6% gain. This might have investors contemplating their next...

Via StockStory

Topics Government Stocks World Trade

The "Ten Titans" Stocks Now Make Up 38% of the S&P 500. Here's What It Means for Your Investment Portfolio ↗

August 24, 2025

Massive growth stocks are driving the performance of the S&P 500, for better or for worse.

Via The Motley Fool

Topics Economy Stocks

Price Over Earnings Overview: Pfizer ↗

August 22, 2025

Via Benzinga

This Is What Whales Are Betting On Pfizer ↗

August 21, 2025

Via Benzinga

3 Unstoppable Dividend Stocks to Buy Right Now ↗

August 23, 2025

Investors will get great dividends and more with these stocks.

Via The Motley Fool

Topics World Trade

My 5 Favorite Stocks to Buy Right Now ↗

August 22, 2025

Not every ticker worth owning at this time has raced to an uncomfortably high price.

Via The Motley Fool

Topics Artificial Intelligence

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years ↗

August 21, 2025

HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a large smoking cessation market.

Via Benzinga

Looking for the most active stocks in the S&P500 index on Thursday? ↗

August 21, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Thursday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans ↗

August 21, 2025

CVS rejected coverage of Gilead's new HIV prevention drug Yeztugo, citing regulatory and financial factors, while facing nearly $290 million in Medicare overcharge penalties.

Via Benzinga

My Top Dividend-Paying, Deep-Value Stock to Buy in August ↗

August 20, 2025

You won't find many stocks with a juicier dividend and more attractive valuation than this big pharma stock.

Via The Motley Fool

Topics Earnings Intellectual Property

2 S&P 500 Stocks to Own for Decades and 1 We Ignore

August 20, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Q2 Earnings Roundup: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Segment

August 19, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how generic pharmaceuticals stocks fared in Q2, starting with...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Viking Therapeutics Plummets as Oral Obesity Drug Trial Raises Tolerability Concerns

August 19, 2025

San Diego, CA – Viking Therapeutics (NASDAQ: VKTX) experienced a dramatic stock decline today following the release of disappointing clinical trial results for its highly anticipated oral tablet...

Via MarketMinute

Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market

August 19, 2025

Comtex News Network, Inc. is a content specialist offering actionable news distribution, global syndication, and traffic for your content

Via News Direct

Medicus Pharma (NASDAQ:MDCX) Solution To Vaccine Cold Chain Storage Could Upend $40 Billion+ Market

August 19, 2025

Via AB Newswire

Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True? ↗

August 19, 2025

Pfizer's yield is high, and so too is its payout ratio.

Via The Motley Fool

3 Hyped Up Stocks That Fall Short

August 19, 2025

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or...

Via StockStory

Intel, Nvidia, Twilio, Palo Alto Networks, Pfizer: What Sparked Heavy After-Hours Trading In These 5 Stocks? ↗

August 19, 2025

Intel continued its winning run amid news of new strategic investment, while Nvidia saw activity as traders geared up for its quarterly results due next week.

Via Stocktwits

Predicting the Next Rule Breaker Buyout ↗

August 19, 2025

Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table?

Via The Motley Fool

Topics Artificial Intelligence

These S&P500 stocks are the most active in today's session ↗

August 18, 2025

Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session.

Via Chartmill

Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform

August 18, 2025

Via AB Newswire

These 3 Dividend Stocks Have Yields Above 5%, Plus They Raise Their Payouts Every Year ↗

August 18, 2025

These three businesses have been raising their payouts for at least 16 consecutive years.

Via The Motley Fool

Winners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks

August 17, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q2, starting with...

Via StockStory

Topics Artificial Intelligence Intellectual Property

2 Top Dividend Stocks to Buy on the Dip ↗

August 16, 2025

These blue chip healthcare stocks could still deliver strong long-term returns.

Via The Motley Fool

Topics Earnings Intellectual Property

Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet. ↗

August 16, 2025

Viking Therapeutics' dual-formulation obesity drug could be the David to Lilly's Goliath.

Via The Motley Fool

Topics Economy

Pfizer's Investigational Drug Flunks Late-Stage For Sickle Cell Disease ↗

August 15, 2025

Pfizer's Phase 3 trial of inclacumab in sickle cell disease misses its main goal but shows safety, with further updates on other drugs planned.

Via Benzinga

3 Long-Term Dividend Buys You Can Get for Under $50 ↗

August 15, 2025

Discover three undervalued dividend stocks under $50 that offer income, growth potential, and strong total returns for value investors

Via MarketBeat

After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again? ↗

August 15, 2025

Pfizer beat expectations last quarter and it raised its guidance.

Via The Motley Fool

Topics World Trade

Celcuity Expenses Jump 81 Percent ↗

August 14, 2025

Via The Motley Fool

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Pfizer (NY:PFE)

All News about Pfizer

Starting at $3.75/week.

Subscribe Today